CINCINNATI--(BUSINESS WIRE)--Eyas Medical Imaging is proud to announce the first installation of the groundbreaking neonatal Magnetic Resonance Imaging (MRI) system, the Ascent 3T™, within the ...
Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Ascent3T™ Neonatal Magnetic Resonance Imaging (MRI) System, a whole-body magnetic resonance ...
The US Food and Drug Administration (FDA) on Thursday announced it has cleared the first magnetic resonance imaging (MRI) device intended to be used on newborns in neonatal intensive care units (NICUs ...
Diffusion-weighted MRI can help predict severe neurological outcomes in infants, enabling early diagnosis of cerebral palsy and delays from hypoxic brain injury Diffusion-weighted MRI will be the ...
Growing emphasis on neonatal brain injury assessment, transport-risk reduction in intensive care units, and expanding NICU infrastructure are driving global demand for specialized neonatal MRI systems ...
The Food and Drug Administration on Thursday approved Aspect Imaging’s MRI device for infants in the neonatal intensive care unit. The Embrace Neonatal MRI System, which is specially designed for ...
Cincinnati medtech startup Eyas Medical Imaging is leveling up, signing a lease for a new headquarters as it gets ready to roll out its Ascent3T neonatal MRI system to hospitals following recent ...
The US Food and Drug Administration (FDA) has granted 510(k) clearance for Eyas Medical Imaging’s Ascent³ᵀ neonatal magnetic resonance imaging (MRI) system, a device engineered specifically for the ...
“510(k) clearance marks a significant milestone for the company and reflects our mission to enable healthcare professionals to save more babies’ lives with state-of-the-art, precision imaging,” said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results